Liver health Medicines Approved in the EU (EMA)

• 48medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 22Oct2026

  Lynavoy

  Active substance: Linerixibat

  EMEA/H/C/006241
• 26Mar2026

  Kayshild

  Active substance: semaglutide

  EMEA/H/C/006426
• 18Aug2025

  Rezdiffra

  Active substance: resmetirom

  EMEA/H/C/006220
• 28Mar2025

  Eltrombopag Accord

  Active substance: eltrombopag olamine

  EMEA/H/C/006459
• 12Dec2024

  Eltrombopag Viatris

  Active substance: eltrombopag olamine

  EMEA/H/C/006417
• 19Sep2024

  Iqirvo

  Active substance: Elafibranor

  EMEA/H/C/006231
• 19Sep2024

  Kayfanda

  Active substance: odevixibat sesquihydrate

  EMEA/H/C/006462
• 7Dec2023

  Elucirem

  Active substance: Gadopiclenol

  EMEA/H/C/005626
• 7Dec2023

  Vueway

  Active substance: Gadopiclenol

  EMEA/H/C/006172
• 26May2023

  Qaialdo

  Active substance: spironolactone

  EMEA/H/C/005535
• 16Jul2021

  Bylvay

  Active substance: odevixibat

  EMEA/H/C/004691
• 21Jun2021

  Jayempi

  Active substance: azathioprine

  EMEA/H/C/005055
• 18Feb2021

  Heplisav B

  Active substance: hepatitis B surface antigen

  EMEA/H/C/005063
• 31Jul2020

  Hepcludex

  Active substance: bulevirtide acetate

  EMEA/H/C/004854
• 20Jun2019

  Doptelet

  Active substance: avatrombopag maleate

  EMEA/H/C/004722

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• Hepatitis
• Infectious diseases
• Obesity